BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Deals

  ULURU Inc. Announces Divestiture of Zindaclin(R)

  June 28, 2010

   · 

  2 min read
• Drug Development

  New Bristol-Myers Squibb Company, AstraZeneca PLC Diabetes Drug, Dapagliflozin Effective in Study

  June 28, 2010

   · 

  9 min read
• Drug Development

  Amylin Pharmaceuticals, Inc.: BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at American Diabetes Association 2010

  June 28, 2010

   · 

  11 min read
• Drug Development

  Biodel Inc. Studies Demonstrate Potential Benefits of More-Rapid-Acting Injectable Insulins: Poster Presentations at Annual Meeting of the American Diabetes Association

  June 28, 2010

   · 

  6 min read
• Drug Development

  Daiichi Sankyo, Inc. New Data Demonstrated Efficacy and Safety of Initial Combination Therapy with Welchol(R) (colesevelam HCl) and Metformin in Drug-Naive Adult Type 2 Diabetes Patients

  June 28, 2010

   · 

  11 min read
• Pharm Country

  India’s Sun Pharmaceutical Industries Ltd to Stop Selling Eloxatin Generic

  June 28, 2010

   · 

  1 min read
• Drug Development

  Tarix Pharmaceuticals’ TXA127 Receives FDA Orphan Drug Designation for Stem Cell Engraftment

  June 28, 2010

   · 

  2 min read
• Drug Development

  Two New Studies Cite Heart Risk in GlaxoSmithKline’s Avandia

  June 28, 2010

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company Release: ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy Provided 76-Week Long-Term Glycemic Control in Treatment-Naïve Adults With Type 2 Diabetes

  June 28, 2010

   · 

  1 min read
• Drug Development

  Preclinical Results With XOMA (US) LLC 052 in Type 2 Diabetes Presented at American Diabetes Association 70th Scientific Sessions

  June 28, 2010

   · 

  1 min read